首页> 外文期刊>Tumour biology : >Potential role of miR-100 in cancer diagnosis, prognosis, and therapy
【24h】

Potential role of miR-100 in cancer diagnosis, prognosis, and therapy

机译:miR-100在癌症诊断,预后和治疗中的潜在作用

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) are small non-coding RNAs that function by base pairing with messenger RNAs, thereby regulating protein expression. Functional studies indicate that miRNAs are involved in the regulation of almost every biological pathway. Moreover, changes in miRNA expression are associated with several human pathologies, including cancer. Dysregulation and aberrant expression of microRNA-100 (miR-100) have been reported to be involved in tumorigenesis and tumor progression of several cancer types, suggesting that miR-100 might serve as a diagnostic and/or prognostic marker for human malignancy. In this review, we summarize the potential application of miR-100 in cancer treatment and as a new molecular marker for cancer prognosis and diagnosis. We will provide a brief introduction to miR-100 and discuss its role as a non-invasive biomarker and a potential therapeutic target in human cancers.
机译:微小RNA(miRNA)是小的非编码RNA,通过与信使RNA碱基配对起作用,从而调节蛋白质表达。功能研究表明,miRNA参与了几乎所有生物途径的调控。此外,miRNA表达的变化与多种人类疾病有关,包括癌症。据报道,microRNA-100(miR-100)的失调和异常表达与几种癌症类型的肿瘤发生和肿瘤进展有关,这表明miR-100可能充当人类恶性肿瘤的诊断和/或预后标志物。在这篇综述中,我们总结了miR-100在癌症治疗中的潜在应用,并将其作为癌症预后和诊断的新分子标记。我们将简要介绍miR-100,并讨论其作为非侵入性生物标志物的作用以及在人类癌症中的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号